These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11996089)

  • 1. By-passing of P-glycoprotein using immunoliposomes.
    Huwyler J; Cerletti A; Fricker G; Eberle AN; Drewe J
    J Drug Target; 2002 Feb; 10(1):73-9. PubMed ID: 11996089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
    Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
    J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.
    Schnyder A; Krähenbühl S; Drewe J; Huwyler J
    J Drug Target; 2005 Jun; 13(5):325-35. PubMed ID: 16199376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.
    Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J
    Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain drug delivery of small molecules using immunoliposomes.
    Huwyler J; Wu D; Pardridge WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14164-9. PubMed ID: 8943078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibility of active targeting to tumor tissues with liposomes.
    Maruyama K; Ishida O; Takizawa T; Moribe K
    Adv Drug Deliv Rev; 1999 Nov; 40(1-2):89-102. PubMed ID: 10837782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells.
    Kessner S; Krause A; Rothe U; Bendas G
    Biochim Biophys Acta; 2001 Oct; 1514(2):177-90. PubMed ID: 11557019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
    Gosk S; Vermehren C; Storm G; Moos T
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of blood-brain barrier transferrin receptor by confocal fluorescent microscopy of unfixed isolated rat brain capillaries.
    Huwyler J; Pardridge WM
    J Neurochem; 1998 Feb; 70(2):883-6. PubMed ID: 9453586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
    Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
    Koning GA; Morselt HW; Velinova MJ; Donga J; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
    Biochim Biophys Acta; 1999 Aug; 1420(1-2):153-67. PubMed ID: 10446299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome.
    Ng K; Zhao L; Liu Y; Mahapatro M
    Int J Pharm; 2000 Jan; 193(2):157-66. PubMed ID: 10606778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
    Koning GA; Kamps JA; Scherphof GL
    Cancer Detect Prev; 2002; 26(4):299-307. PubMed ID: 12430634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
    Kang YS; Jung HJ; Oh JS; Song DY
    CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins.
    Mastrobattista E; Koning GA; van Bloois L; Filipe AC; Jiskoot W; Storm G
    J Biol Chem; 2002 Jul; 277(30):27135-43. PubMed ID: 12021269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.